Clinical Trials Browser

OTHER × Prostatic Neoplasms × Tablets × Clear all

NCT05265988 2024-07-31

MERIDIAN

Phase 2 Completed

Prostatic Neoplasms

NCT04658849 2023-05-15

Insulin Resistance Following ADT for Prostate CA

Phase EARLY_PHASE1 Withdrawn

Insulin Resistance, Prostatic Neoplasms